Brilliant Violet 605TM anti-human CD4 [OKT4] and 2 more items

BioLegend Inc. was awarded a contract by the University of Virginia on July 15, 2026, for the delivery of specialized laboratory reagents to support flow cytometry research and analysis. The contract, valued at $625, encompasses three distinct fluorescently-labeled monoclonal antibodies designed for human immunophenotyping applications. These line items include Brilliant Violet 605 anti-human CD4 [OKT4] ($318 per unit), Alexa Fluor 700 anti-human CD19 [HIB19] ($187.60 per unit), and Alexa Fluor 700 anti-human CD11b [ICRF44] ($119.70 per unit), with all deliveries directed to Trudy D. Robinson at the University of Virginia.

The contract represents a procurement of research-grade biological reagents, with delivery quantities of one unit each for all three line items. These antibody conjugates are used in multiparameter flow cytometric analysis for identifying and characterizing specific populations of human immune cells, including T lymphocytes, B lymphocytes, and myeloid cells. The award was made in Virginia and reflects the University of Virginia's ongoing need for quality-assured diagnostic and research reagents from established suppliers in the life sciences reagent market.